| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Sandler Laura Lee serves as a Chief Operating Officer at ORKA. Across recent SEC filings that breaks down to 0 buys and 19 sells. Those positions are worth an estimated $22.5M at current prices.
The biggest single holding is ORKA (~$22.5M) as Chief Operating Officer. The recent filings there lean toward selling, a net 35,106 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | ORKA Oruka Therapeutics, Inc. | Chief Operating Officer | Sell | 906 | $95.71 | $86,713.26 | -0.4% | - | - | |
| Sep 1, 2026 | ORKA Oruka Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 5,000 | $91.82 | $459,101.20 | -2.1% | - | - | |
| Jul 1, 2026 | ORKA Oruka Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 5,000 | $94.42 | $472,078.58 | -2.1% | - | - | |
| Jun 15, 2026 | ORKA Oruka Therapeutics, Inc. | Chief Operating Officer | Sell | 600 | $69.69 | $41,814.00 | -0.3% | - | - | |
| May 1, 2026 | ORKA Oruka Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 5,000 | $63.88 | $319,384.30 | -2.1% | - | - | |
| Mar 16, 2026 | ORKA Oruka Therapeutics, Inc. | Chief Operating Officer | Sell | 600 | $41.30 | $24,780.00 | -0.3% | - | - | |
| Mar 2, 2026 | ORKA Oruka Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 5,000 | $33.56 | $167,821.59 | -2.1% | - | - | |
| Jan 2, 2026 | ORKA Oruka Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 13,000 | $28.52 | $370,795.08 | -6.0% | +78.4% | - |